🇮🇳IN
Sign In
LI

LINCOLN

NSE

Lincoln Pharmaceuticals Limited

₹504.35

-10.25(-1.99%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

LINCOLN valuation summary

Lincoln Pharmaceuticals Limited trades at 10.3 times trailing earnings. Return on equity is 12.0% and return on capital employed is 16.0%. The dividend yield is 0.36%.

P/E10.3
ROE12.0%
ROCE16.0%
Dividend yield0.36%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer